NEW YORK (360Dx) – NeoGenomics announced after the close of the market on Thursday that it expects third quarter revenues of approximately $63.1 million, and estimated that hurricanes Harvey and Irma depressed revenues by approximately $1 million.

The estimated Q3 2017 revenues would be a 4 percent increase year over year from Q3 2016 revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.

Nov
14
Sponsored by
PerkinElmer

In these times of economic constraint and increasing research costs, shared resource cores have become a cost-effective and essential platform for researchers who seek to investigate complex translational research questions.